| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2006 | EP1625205A2 Ancestral viruses and vaccines |
| 02/15/2006 | EP1625199A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 02/15/2006 | EP1625167A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compositions comprising them |
| 02/15/2006 | EP1625164A1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 02/15/2006 | EP1625163A1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 |
| 02/15/2006 | EP1625161A1 A synthetic bioelastomer |
| 02/15/2006 | EP1625160A1 A bioelastomer |
| 02/15/2006 | EP1625159A1 Materials and methods relating to g-protein coupled receptor oligomers |
| 02/15/2006 | EP1625158A2 Peptides for use in treating obesity |
| 02/15/2006 | EP1625157A2 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation |
| 02/15/2006 | EP1625156A2 Peptides that bind to the erythropoietin receptor |
| 02/15/2006 | EP1625155A1 Novel antimicrobial peptides with heparin binding activity |
| 02/15/2006 | EP1625154A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket |
| 02/15/2006 | EP1625151A2 Comparative ligand mapping from mhc class i positive cells |
| 02/15/2006 | EP1625148A1 Peptide complex |
| 02/15/2006 | EP1625145A1 Extraction process for a pharmaceutical product |
| 02/15/2006 | EP1625144A2 Polyvalent immunogen |
| 02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
| 02/15/2006 | EP1624892A2 Therapeutic use of anti-cs1 antibodies |
| 02/15/2006 | EP1624890A2 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes |
| 02/15/2006 | EP1624888A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccine |
| 02/15/2006 | EP1624884A2 Somatostatin vectors |
| 02/15/2006 | EP1624847A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 02/15/2006 | EP1624748A2 A transgenic animal model for cancer and stem cells |
| 02/15/2006 | EP1328652B1 Non-human transgenic animal expressing ca-ahr |
| 02/15/2006 | EP1283676B1 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings |
| 02/15/2006 | EP1065269B1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 02/15/2006 | EP0840794B1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
| 02/15/2006 | EP0795021B1 Retroviral delivery of full length factor viii |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735689A Bacterial virulence genes |
| 02/15/2006 | CN1735687A MK2 interacting proteins |
| 02/15/2006 | CN1735686A Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 02/15/2006 | CN1735684A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 02/15/2006 | CN1735628A Polypeptides F' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 02/15/2006 | CN1735426A Peptides as solubilizing excipients for transforming growth factor ss proteins |
| 02/15/2006 | CN1735423A Treatment of gastroparesis |
| 02/15/2006 | CN1733922A Super antigen fusion protein and its application method |
| 02/15/2006 | CN1733921A Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression |
| 02/15/2006 | CN1733920A Soybean disease-resistant gene and its coded protein and uses |
| 02/15/2006 | CN1733918A Motilin homologs |
| 02/15/2006 | CN1733803A Lung carcinoma early stage serum specific protein and its uses |
| 02/15/2006 | CN1733802A Plant DREB transcription factor and its coding gene and uses |
| 02/15/2006 | CN1733801A Extraction method and uses of traditional Chinese medicine cassia seed protein |
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/15/2006 | CN1733799A Gene mutated archaerhodopsin 4 protein and its preparation method and uses |
| 02/15/2006 | CN1733798A Hepatitis B virus surface L protein related peptide |
| 02/15/2006 | CN1242062C Method for producing a peptide with a pi above 8 or below 5 |
| 02/15/2006 | CN1242061C Short finger gene |
| 02/15/2006 | CN1241946C Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 02/15/2006 | CN1241945C Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 02/15/2006 | CN1241944C Antibody againts 'alpha'-chain of human interleukin 5 receptor |
| 02/15/2006 | CN1241943C Method for extracting insulin-like growth factor (IGF-1) from fresh antler |
| 02/15/2006 | CN1241942C Methods for treatment of diabetes using peptide analogues of insulin |
| 02/15/2006 | CN1241941C Protein for promoting nerve differentiation and resisting cell death, and its coding gene |
| 02/15/2006 | CN1241940C Novel collagen-like protein CLAC, Precursor thereof and genes encoding the same |
| 02/15/2006 | CN1241939C Gene BjCET4 of Indian mustard cation output transporting proteins and its protein |
| 02/15/2006 | CN1241938C Purification technique in preparing genetic engineering vaccine of heat shock protein A of recombined Helicobacter pylori |
| 02/15/2006 | CN1241937C Polyvalent pneumococcal polysaccharide combination vaccine |
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/15/2006 | CN1241548C Stable protein: phospholipid composition and method |
| 02/14/2006 | US6998517 Promoter linked to nucleotide, introduced to the plant using Agrobacterium; gene expression inhibition |
| 02/14/2006 | US6998515 Use of a nucleic acid encoding a hypersensitive response elicitor polypeptide to enhance growth in plants |
| 02/14/2006 | US6998478 The promoter controls specific gene expression at the transcriptional level in cotton fibers so may be used in improving cotton fibers to create new cotton varieties with high fiber quality and yield by gene manipulation. |
| 02/14/2006 | US6998477 the fragment has promotes expression of a structural gene located at a downstream site; a plant in which expression of a desired structural gene is promoted |
| 02/14/2006 | US6998476 Nucleic acids encoding antagonists of interleukin-15 |
| 02/14/2006 | US6998475 Variants of traf2 which act as an inhibitor of tnf-alpha (tnfα) signaling pathway |
| 02/14/2006 | US6998474 used for prevention and/or treatment of pathologies, dysfunctions, disorders or conditions affecting the nervous system |
| 02/14/2006 | US6998473 isolated polynucleotide molecules which encode the isoforms ; methods of screening compounds for vitamin D receptor (VDR) agonists and/or antagonists |
| 02/14/2006 | US6998472 Obesity gene |
| 02/14/2006 | US6998470 by using diafiltration, solid phase extraction and immunoaffinity techniques |
| 02/14/2006 | US6998469 for treating thrombosis and other vascular diseases |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998383 Inhibitors of receptor activator of NF-κB and uses thereof |
| 02/14/2006 | US6998267 transformed plant cell is obtained by introducing to a plant cell a gene encoding a glycosyltransferase enzyme and a gene encoding an exogenous glycoprotein, cultivating the obtained transformed plant cell |
| 02/14/2006 | US6998255 polynucleotides and polypeptides relating to a G-protein coupled receptor, IGS4, which exists in two polymorphic forms, IGS4A and IGS4B; use as therapeutic target and for treatment of PNS, psychiatric and CNS disorders, including schizophrenia |
| 02/14/2006 | US6998252 vaccinia virus modified by insertion of chimeric gene containing vaccinia regulatory sequences or DNA sequences functionally equivalent thereto flanking DNA sequences which to nature are not contiguous with flanking vaccinia regulatory dna sequence |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998240 Screen for selective inhibitors or activators of Smad protein function |
| 02/14/2006 | US6998239 contacting an isolated or recombinant CCX CKR polypeptide or, a fragment or variant, and the chemokine in the presence of a test compound, comparing the level of binding of the chemokine and the polypeptide |
| 02/14/2006 | US6998238 Method for determining MIF content |
| 02/14/2006 | US6998233 Methods for ligand discovery |
| 02/14/2006 | US6998232 determining, in a sample from a human subject, the level of expression of at least two polynucleotides, wherein a higher level of expression of the polynucleotides compared to cancer free human polynucleotide expression is an indication of cancer |
| 02/14/2006 | US6998229 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample |
| 02/14/2006 | US6998123 interleukins (IL-11); fibronectins; glycoproteins |
| 02/14/2006 | US6998118 Transducing neuron with gene; Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis |
| 02/14/2006 | US6998117 Cancer treatment with retroviral vectors comprising wild-type p53 |
| 02/14/2006 | US6998116 tumor necrosis factor related cytokines which induce apoptosis; for treatment of cancer/glioblastomas |
| 02/14/2006 | CA2384170C Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same |
| 02/14/2006 | CA2383391C Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 02/14/2006 | CA2378533C Erythropoietin conjugates with polyethylenglycol |
| 02/14/2006 | CA2336597C Hepatitis c inhibitor peptides |
| 02/14/2006 | CA2307060C Nucleic acids having promoter activity and transgenic plants containing the same |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/14/2006 | CA1341497C Biologically active fragments of human antihemophilic factor and method for preparation thereof |
| 02/14/2006 | CA1341496C Production of thrombin inhibitors |
| 02/09/2006 | WO2006015368A2 Molecules with effects on cellular development and function |
| 02/09/2006 | WO2006015365A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 02/09/2006 | WO2006015165A2 Optimized interferon-beta gene |